Skip to main content
YARW
NASDAQ Life Sciences

Yarrow Bioscience Launches Underwritten Public Offering to Fund Pipeline

Tom Rudovsky · Reported by BusinessWire
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$28.44
Mkt Cap
$75.928M
52W Low
$14.165
52W High
$46.95
52W Position info
101% above low
Off High info
39% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

YARW has more than doubled off its 52-week low of $14.165.

Summary

Yarrow Bioscience announced an underwritten public offering of common stock or pre-funded warrants, with an option for underwriters to purchase up to an additional 15% of shares. The offering size and pricing are not yet disclosed, but the company intends to use proceeds for R&D and general corporate purposes. This follows the recent merger with VYNE Therapeutics and the initiation of a Phase 2a/2b trial for YB-101. The offering will dilute existing shareholders, and the lack of specific terms adds uncertainty. Jefferies, TD Cowen, and Guggenheim are joint book-running managers, with LifeSci Capital as lead manager. The shelf registration was declared effective on August 19, 2026.

At the time of this announcement, YARW was trading at $28.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $75.9M. The 52-week trading range was $14.17 to $46.95. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

YARW - Latest Insights

YARW
Sep 14, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $26.26
Real-time Price: $13.40 info
Change: -$12.86 (-49%) info
Market Cap: $128.353M info
YARW
Sep 14, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.26
Real-time Price: $13.40 info
Change: -$12.86 (-49%) info
Market Cap: $128.353M info
YARW
Sep 11, 2026, 4:52 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $27.01
Real-time Price: $13.40 info
Change: -$13.61 (-50%) info
Market Cap: $128.353M info
YARW
Sep 11, 2026, 4:44 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $27.01
Real-time Price: $13.40 info
Change: -$13.61 (-50%) info
Market Cap: $128.353M info
YARW
Sep 10, 2026, 9:11 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $27.25
Real-time Price: $13.40 info
Change: -$13.85 (-51%) info
Market Cap: $128.353M info